LEADER 03726nam 22005535 450 001 9910300095203321 005 20200702121635.0 010 $a1-4614-8271-2 024 7 $a10.1007/978-1-4614-8271-0 035 $a(CKB)3710000000073708 035 $a(EBL)1592885 035 $a(SSID)ssj0001067134 035 $a(PQKBManifestationID)11602473 035 $a(PQKBTitleCode)TC0001067134 035 $a(PQKBWorkID)11079179 035 $a(PQKB)11267290 035 $a(MiAaPQ)EBC1592885 035 $a(DE-He213)978-1-4614-8271-0 035 $a(PPN)176098526 035 $a(EXLCZ)993710000000073708 100 $a20131118d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAdvances in Diagnosis and Management of Ovarian Cancer /$fedited by Samir A. Farghaly 205 $a1st ed. 2014. 210 1$aNew York, NY :$cSpringer US :$cImprint: Springer,$d2014. 215 $a1 online resource (280 p.) 300 $aDescription based upon print version of record. 311 $a1-4614-8270-4 320 $aIncludes bibliographical references and index. 327 $a1. Epidemiology of Ovarian Cancer: An Update -- 2. Genetic Risks of Ovarian Cancer -- 3. Management of Hereditary Ovarian?Breast Cancer -- 4. Ovarian Cancer Screening  and Early Detection -- 5. Surface Epithelial Tumors of the Ovary -- 6. Pathology of Non Epithelial Malignancies of the Ovary -- 7. Strategies for the Management of Ovarian Cancer -- 8. Ovarian Cancer in the Pediatric Population -- 9. Management of Patients with Early-Stage Ovarian Cancer -- 10. Treatment of Advanced-Stage Ovarian Cancer -- 11. Diagnosis and Management of Epithelial Ovarian Cancer with Peritoneal Metastases -- 12. Targeted Molecular Therapy for Patients with Ovarian Cancer -- 13. Psychological Aspects of Hereditary and Non-Hereditary Ovarian Cancer -- 14. Quality of Life in Patients with Ovarian Cancer. 330 $aThis volume is an up-to-date resource on the international state-of-the-art in the diagnosis and management of ovarian cancer.  While this devastating disease has been considered mainly a disease of the Western hemisphere, the book moves beyond our conventional understanding and embraces knowledge from around the world. It focuses on recent advances in diagnosis, including genetic screening; improvements and expanded choices in management, such as gene therapy and the optimization of chemotherapeutic agents; and the latest laparoscopic and robotic surgical techniques. Further chapters address histopathologic features of this disease,  and related psychosocial and quality of-life-issues. The book is aimed at the wide range of practitioners who care for patients with ovarian cancer and researchers who study the disease:  general surgeons, surgical oncologists, gynecological oncologists, medical oncologists, pediatric oncologists, gynecological pathologists, gynecologists, gynecological cancer epidemiologists, gynecological onco-psychologist, genetic counselors, geneticists, and cancer research scientists. 606 $aOncology   606 $aGynecology  606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aGynecology$3https://scigraph.springernature.com/ontologies/product-market-codes/H26006 615 0$aOncology  . 615 0$aGynecology . 615 14$aOncology. 615 24$aGynecology. 676 $a616.99465 702 $aFarghaly$b Samir A$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300095203321 996 $aAdvances in Diagnosis and Management of Ovarian Cancer$91466222 997 $aUNINA